Navegar

Colección

Datos Estadísticas

Artículo

Bonneau, G.A.; Castillo Rascon, M.S.; Pedrozo, W.R.; Ceballos, B.; Leiva, R.; Blanco, N.; Berg, G. "Presence of the insulin resistance in metabolic syndrome " (2006) Revista Argentina de Endocrinologia y Metabolismo. 43(4):215-223
Estamos trabajando para incorporar este artículo al repositorio
Consulte la política de Acceso Abierto del editor

Abstract:

Quantification of insulin-resistance (IR) is a useful tool for evaluating its role in the physiopathology of high-frequency diseases and with high impact on the economy in public health, as well as for identifying high risk groups at its early stages The Third Adult Treatment Panel (ATP-III) has published diagnostic criteria for the Metabolic Syndrome (MS), a cluster of abnormalities related to the IR state that increases the risk of cardiovascular disease. The aim of this present study was to find the reference values of insulin, and for IR markers like HOMA and QUICKI in a healthy population constituted by a group of Public Hospital employees. Another objective was to identify subjects with IR within a sub-group carrier of MS, as defined according to the ATP-III criteria, and to correlate the IR, as evaluated by HOMA and QUICKI indexes, with the different components of the MS. We studied two groups of adult subjects from both sexes, employees at Ramon Madariaga and Province Pediatric Public Hospitals in Posadas City , Misiones Province. One group was constituted by 87 subjects with MS, and the second group by 74 subjects without MS (Control Group). Both groups represented a similar distribution of sex and age. Weight, height and waist circumference were obtained in accordance with WHO standards. Blood pressure was measured with a mercury esphybgomanometer, lipids and lipoproteins were evaluated in 12-hour fast samples, in another blood sample obtained after an 8-hour period of fasting, glycemia and insulinemia were measured. HOMA and QUICKI indexes were calculated. Internal Quality Control was performed with a serum pool prepared in the laboratory, and the External Quality Control was carried out through the controls provided by the Argentine Biochemical Foundation. Insulin was determined by radioimmunoanalysis (CV=8%) in a private laboratory at Posadas City, and for the statistical analysis of the data, Epi Info 6.04 d and SSPS 11-5 version were used. The cut off point for values found in the present study were: 12 mU/l for insulin, 2.6 for HOMA and 0.33 for QUICKI. To define IR, the 95 percentile for insulin and HOMA, and the 10 percentile for QUICKI were used, given the very strict criterion for the selection of the control group, (table 1). Sixty-six percent of the patients with MS presented IR, and no differences were observed when evaluating IR either for HOMA, or for QUICKI (figures III and IV). When correlating each of the parameters of the MS with the IR, HOMA and QUICKI indexes, significant correlations were found only with a waist (p=0.01), glycemia (p=0.01) and triglycerides (p=0.04). Due to the wide variety of cut off points used to define IR, we suggest the finding of own values of reference as those obtained in the present study. According to the surrogate markers used in this study, two thirds of the patients within the MS group presented IR, showing that not all patients with MS are IR, and therefore IR alone would not explain the presence of the MS physiopathology. Copyright © 2006 por la Sociedad Argentina de Endocrinología y Metabolismo.

Registro:

Documento: Artículo
Título:Presence of the insulin resistance in metabolic syndrome
Autor:Bonneau, G.A.; Castillo Rascon, M.S.; Pedrozo, W.R.; Ceballos, B.; Leiva, R.; Blanco, N.; Berg, G.
Filiación:Facultad de Ciencias Exactas Químicas Y Naturales, Universidad Nacional de Misiones, Argentina
Hospital Público Provincial Dr. Ramón Madariaga, Argentina
Facultad de Farmacia Y Bioquímica, Universidad de Buenos Aires, Argentina
Barrio Kennedy casa 62, Posadas, Misiones (3300), Argentina
Idioma: Español
Palabras clave:Cardiovascular risk factors; Insulin resistance; Metabolic syndrome; insulin; lipid; lipoprotein; adult; article; blood pressure measurement; blood sampling; body height; body weight; cardiovascular disease; cardiovascular risk; controlled study; demography; diet restriction; female; glucose blood level; human; insulin blood level; insulin resistance; insulinemia; laboratory test; major clinical study; male; metabolic syndrome X; sex difference; waist circumference
Año:2006
Volumen:43
Número:4
Página de inicio:215
Página de fin:223
Título revista:Revista Argentina de Endocrinologia y Metabolismo
Título revista abreviado:Rev. Argent. Endocrinol. Metab.
ISSN:03264610
CODEN:RAEMA
CAS:insulin, 9004-10-8; lipid, 66455-18-3
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03264610_v43_n4_p215_Bonneau

Referencias:

  • Fleitas Esteves, A., Síndrome X. Alto riesgo de enfermedad arterial (2002) Rev. Cubana Angiol. Y Cir. Vasc., 3 (1), pp. 68-74
  • Bloomgarden, Z.T., Definitions of the Insulin Resistance Syndrome (2004) Diabetes Care, 27 (3), pp. 824-830
  • Gonzalez, C.D., Santoro, S.G., Sinay, I., Farmacología de la Insulinorresistencia: Situación actual y perspectivas (2004) Rev Argent de Endocrinol Metab, 41 (3), pp. 159-169
  • Valmore Bermude, P., Climaco Cano, P., Mayerlim Medina, R., Homeostasis Model Assessment (HOMA) en Pacientes Diabéticos tipo 2 (2000) Med. Int., 16 (3). , (Caracas)
  • De Fronzo, R.A., Tobin, J.D., Andres, R., The glucosa clamp technique: A method for cuantification of beta cell sensitivity to glucosa and of tissue sensitivity to insulin (1979) Am. J. Phisiol., pp. E214-E223
  • Skrha, J., Haas, T., Sindelka, G., Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders (2004) J Clin Endocrinol Metab, 89, pp. 135-141
  • Haffner, S.M., Miettinen, H., Stern, M., The Homeostasis Model in the San Antonio Heart Study (1997) Diabetes Care, 20, pp. 1087-1092
  • Bonora, E., Targher, G., Alberiche, M., Homeostasis Model Assesment Closely Mirrors the Glucosa Clamp Technique in the Assesment of Insulin Sensitivity (2000) Diabetes Care, 23, pp. 57-63
  • Bloomgarden, Z.T., The 1st World Congress on the Insulin Resistance Syndrome (2004) Diabetes Care, 27 (2), pp. 602-609
  • Kuczmarski, R.J., Carroll, M.D., Flegal, K.M., Troyano, R.P., Varying body mass index cut-off points to describe overweight prevalence among U.S. Adults: NHANES III (1988 to 1994) (1997) Obes Res., 5, pp. 542-548
  • Hulthe, J., Bokemark, L., Wikstrand, J., The Metabolic Syndrome, LDL particle size and atherosclerosis: The Atherosclerosis and Insulin Resitance (AIR) Study (2000) Arterioscler Thromb. Vasc. Biol., 20 (9), pp. 2140-2147
  • Reilly, M.P., Rader, D.J., The Metabolic syndrome. More Than the Sum of this Parts? (2003) Circulation, 108, pp. 1546-1551
  • Isomaa, B., Cardiovascular morbidity and mortality associated with the metabolic syndrome (2001) Diabetes Care, 4, pp. 683-689
  • Adult Treatment Panel III (ATP III) (2001) JAMA, 285, pp. 2486-2497. , National Cholesterol Education Panel (NCEP)
  • Physical status: The use and interpretation of anthropometry (1993) WHO Technical Report Series, 854, pp. 429-430. , Report of a WHO Expert Committee. Geneva, World Health Organitation
  • Ascaso, J.F., Pardo, S., Real, J.T., Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism (2003) Diabetes Care, 26, pp. 3320-3325
  • Mc Auley, K., Williams, S., Mann, J., Diagnosing Insulin Resistance in the General Population (2001) Diabetes Care, 24, pp. 460-464
  • Graffigna, M., Litwak, L., Abdala, M., Determinación del Indice HOMA en sujetos presuntamente sanos. Estudio epidemiológico multicéntrico. (resultados preliminares) (2005) Rev. Arg. de Endocrinologia Y Metabolismo, 42 (1), pp. 12-19
  • Wolfthal, D., Buccini, G., Insulinorresistencia y Sindrome metabólico (2004) Bioquímica Y Patología Clínica, 68 (1), pp. 42-43
  • Fontbonne, A., Eschwege, E., Cambien, F., Hypertriglyceridaemia as a risk factor of coronary Herat disease mortality in subjects with impaired glucosa tolerante or diabetes. Results from the 11-year follow-up of the Paris Prospective Study (1989) Diabetología, 32 (5), pp. 300-304
  • Gastelú, R., Trebin, C., Valores de Referencia de Insulina e Indice HOMA para una Metodología ECLIA (2004) Bioquímica Y Patología Clínica, 68 (1), p. 44
  • Mc Laughlin, T., Abbasi, F., Reaven, G., Utilizacion de marcadores Metabolicos para la identificacion de Insulinorresistencia en sujetos obesos (2003) Ann. Intern. Med., 139 (10), pp. 802-804
  • Ruibal, G., Consenso sobre Diagnostico de Insulinorresistencia (2003) Rev de Endocrinologia Gin. Y Reproductiva, 1, pp. 24-27
  • Wallace, T.A., Levy, J.C., Matthews, D.R., Use y Abuse of HOMA Modeling (2004) Diabetes Care, 27, pp. 1487-1495
  • Coniglio, R., Pino, M., Cailotto, M., Indice de Insulinorresistencia y Sindrome metabolico en un grupo Poblacional del Sur Argentino (2001) Rev. Arg. de Cardiología, 3, pp. 35-37
  • Litwak, L., Graffigna, M., Abdala, M., Prevalencia de Factores de Riesgo Cardiovascular en sujetos presuntamente sanos. Estudio epidemiológico Multicéntrico (Capital federal y Gran Buenos Aires) (2004) Rev. Arg. de Endocrinologia Y Metab., 41, pp. 206-213
  • Bonora, E., Kiechi, S., Williet, J., Prevalence of Insulin Resistance in Metabolic Disorders. The Bruneck Study (1998) Diabetes, 47, pp. 1643-1648
  • Lobo, P.E., Martí, M.L., Preiti, M., Ausencia de concordancia entre Insulinorresistencia y el Sindrome metabolico ATP III (2004) Rev. Soc. Arg. de Diabetes, 38 (3), p. 163
  • Cheal, K., Abassi, F., Lamendola, C., Relationship to Insulin Resistance of Adult Treatment Panel III Diagnostic Criteria for Identification of the Metabolic Syndrome (2004) Diabetes, 53, pp. 1195-1200
  • Liao, Y., Kwon, S., Wallace, P., Critical evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance with Dyslipemia (2004) Diabetes Care, 27 (4), pp. 978-983
  • Mc Laughlin, T., Reaven, G., Abbasi, F., Is there a Simple Way to Identify Insulin-Resistant Individuals al Increased Risk of Cardiovascular Disease? (2005) The American Journal of Cardiology, 96, pp. 399-404
  • Ascaso, J.E., Romero, P., Real, J.T., Abdominal obesity, Insulin resistance and metabolic syndrome in a southern European population (2003) European Journal of Internal Medicine, 14, pp. 101-106
  • Hanley, A., Karter, A., Festa, A., Factor Analysis of metabolic Syndrome Using Directly Measured Insulin Sensitivity. The Insulin Resistance Atherosclerosis Study (2002) Diabetes, 51, pp. 2642-2647
  • Solymoss, C., Bourassa, M., Campeau, L., Effect of Increasing Metabolic Syndrome Score on Atherosclerotic Risk Profile and Coronary Artery Disease Angiografic Severity (2004) The American Journal of Cardiology, 93, pp. 159-165
  • Wahrenberg, H., Hertel, K., Leijonhufvud, B., Use of waist circumference to predict Insulin Resistance: Retrospective study (2005) BMJ Journal, 330, pp. 1363-1364
  • Reaven, G., Compensatory Hyperinsulinemia and the Development of an Atherogenic Lipoprotein Profile: The Price paid to Maintain Glucose Homeostasis in Insulin-Resistant Individuals (2005) Endocrinology and Metabolism Clinics of North America, 34, pp. 49-62
  • Flegal, K.M., Carroll, M.D., Ogden, C.I., Jonson, C.L., Prevalence and trends in obesity among US adults, 1999-2000 (2002) JAMA, 288, pp. 1723-1727

Citas:

---------- APA ----------
Bonneau, G.A., Castillo Rascon, M.S., Pedrozo, W.R., Ceballos, B., Leiva, R., Blanco, N. & Berg, G. (2006) . Presence of the insulin resistance in metabolic syndrome . Revista Argentina de Endocrinologia y Metabolismo, 43(4), 215-223.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03264610_v43_n4_p215_Bonneau [ ]
---------- CHICAGO ----------
Bonneau, G.A., Castillo Rascon, M.S., Pedrozo, W.R., Ceballos, B., Leiva, R., Blanco, N., et al. "Presence of the insulin resistance in metabolic syndrome " . Revista Argentina de Endocrinologia y Metabolismo 43, no. 4 (2006) : 215-223.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03264610_v43_n4_p215_Bonneau [ ]
---------- MLA ----------
Bonneau, G.A., Castillo Rascon, M.S., Pedrozo, W.R., Ceballos, B., Leiva, R., Blanco, N., et al. "Presence of the insulin resistance in metabolic syndrome " . Revista Argentina de Endocrinologia y Metabolismo, vol. 43, no. 4, 2006, pp. 215-223.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03264610_v43_n4_p215_Bonneau [ ]
---------- VANCOUVER ----------
Bonneau, G.A., Castillo Rascon, M.S., Pedrozo, W.R., Ceballos, B., Leiva, R., Blanco, N., et al. Presence of the insulin resistance in metabolic syndrome . Rev. Argent. Endocrinol. Metab. 2006;43(4):215-223.
Available from: https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03264610_v43_n4_p215_Bonneau [ ]